Cellerant Therapeutics
Latest round
- Series B
Last raised
- Apr 2011
Total raised
- $44M
Investors
- 7
About Cellerant Therapeutics
Founded in 2003 and headquartered in San Carlos, US, Cellerant Therapeutics specializes in cellular therapies. The firm has not indicated any pivots in business strategy. CEO Ram Mandalam leads the company, which has completed a total of 18 deals.Cellerant Therapeutics provides innovative cellular therapies aimed at treating hematologic malignancies and various other healthcare challenges. Their core offerings include proprietary technology-driven platforms that improve treatment outcomes for patients. These therapies are tailored to address the needs of healthcare providers, ensuring effective patient management and care.Cellerant Therapeutics generates revenue through a structured model primarily based on partnerships with healthcare providers.Cellerant Therapeutics aims to expand its product line with new cellular therapies designed to address additional hematologic conditions by 2025. The company also plans to increase its market presence in Europe and Asia, targeting healthcare sectors in these regions for growth.5 mn will be utilized to support the development of these upcoming therapies and facilitate their entry into new markets.
Who invested in Cellerant Therapeutics
7 investors across 6 rounds
See all investors in Cellerant Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cellerant Therapeutics
Who invested in Cellerant Therapeutics?
Cellerant Therapeutics has 7 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cellerant Therapeutics raised?
Cellerant Therapeutics has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Cellerant Therapeutics last raise money?
Cellerant Therapeutics's most recent round on record is a Series B, in Apr 2011.
What does Cellerant Therapeutics do?
Founded in 2003 and headquartered in San Carlos, US, Cellerant Therapeutics specializes in cellular therapies.
Where is Cellerant Therapeutics headquartered?
Cellerant Therapeutics is headquartered in San Carlos, US.
Which VCs invest in companies like Cellerant Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Cellerant Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Cellerant Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.